Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer
- 4 July 2006
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 100 (2) , 213-218
- https://doi.org/10.1007/s10549-006-9245-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Haplotype Analysis of HER-2 Gene Polymorphisms: Association with Breast Cancer Risk, HER-2 Protein Expression in the Tumor, and Disease Recurrence in KoreaClinical Cancer Research, 2005
- Genetic Polymorphisms of SULT1A1 and SULT1E1 and the Risk and Survival of Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- Simultaneous Selection of the Wild‐type Genotypes of the G894T and 4B/ 4A Polymorphisms of NOS3 Associate with High‐altitude AdaptationAnnals of Human Genetics, 2005
- Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancerGynecologic Oncology, 2004
- Augmented endothelial nitric oxide synthase (eNOS) protein expression in human pregnant myometrium: possible involvement of eNOS promoter activation by estrogen via both estrogen receptor (ER) and ERMolecular Human Reproduction, 2004
- Vascular invasion in human breast cancer is correlated to T→786C polymorphism of NOS3 geneNitric Oxide, 2003
- Nitric oxide‐mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen‐activated protein kinaseInternational Journal of Cancer, 2003
- The role of nitric oxide in cancerCell Research, 2002
- T −786 →C Mutation in the 5′-Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary SpasmCirculation, 1999
- Evidence of Association of the ecNOS Gene Polymorphism with Plasma NO Metabolite Levels in HumansBiochemical and Biophysical Research Communications, 1998